Table 1.
Demographic, sonographic, laboratory, and operative findings of women with ectopic pregnancy treated with methotrexate who underwent urgent surgical intervention
| N = 43 | Tubal rupture (15) 34.9% |
Tubal abortion (28) 65.1% |
P value |
|---|---|---|---|
| Age, median (range) | 34 (25–41) | 31 (23–41) | 0.444* |
| Abortion, median (range) | 0 (0–2) | 0 (0–3) | 0.521* |
| Gravidity, median (range) | 3 (1–6) | 3 (1–6) | 0.822* |
| Parity, median (range) | 2 (0–4) | 2 (0–5) | 0.810* |
| EP in the past, (N)% | (1) 6.7% | (0) | 0.349** |
| EP Gestational age at MTX treatment (weeks), median(range) | 6.5 (5–9) | 6 (5–9) | 0.209* |
| Clinical findings | |||
| Abdominal pain, (N)% | 15 (100%) | 22 (78%) | 0.076*** |
| Nausea and vomiting, (N)% | 3 (20%) | 4 (14.3%) | 0.680*** |
| Dizziness, (N)% | 1 (6,7%) | 1 (3.6%) | 1.000** |
| Shoulder pain, (N)% | 2 (13.3%) | 1 (3.6%) | 0.275** |
| Abdominal tenderness, (N)% | 8 (53.3%) | 10 (35.7%) | 0.338*** |
| Preoperative TVS findings | |||
| EP by TVS- preoperative, (N)% | 12 (85.7%) | 23 (82.1%) | 1.000** |
| EP size By TVS(cm), median (range) | 2.3 (1–4) | 1.5 (1–5) |
0.097* 2S 0.049* 1S |
| Free fluid, (N)% | 9 (64.3%) | 8 (28.6%) | 0.045*** |
| Endometrium thickness(mm), median (range) | 4 (2–15) | 7 (5–25) | 0.293* |
| Laboratory findings | |||
| preoperative Bhcg, mean (± sd) | 3337.6 (± 3168.3) | 2166.6 (± 2327.4) | 0.174# |
| Preoperative hemoglobin, mean (± sd) | 11.4 (± 1.4) | 11.8 ± 0.9 | 0.329# |
| Postoperative hemoglobin, mean (± sd) | 10.1 (± 1.3) | 10.5 ± 0.9 | 0.269# |
| Blood loss (cc), mean (± sd) | 433 (± 143) | 250 ± 201 | 0.001# |
* Mann–Whitney, ** Fisher’s, *** Chi-square, # t-test